FDA OKs First Influenza Vaccine Cultured in Insect Cells

CIDRAP has announced that the FDA has approved Flublok, the very first flu vaccine produced with the aid of an insect virus and recombinant DNA technology.

As quoted in the market news:

Karen Midthun, MD, director of the FDA’s Center for Biologics Evaluation and Research, called Flublok a technological advance. “The new technology offers the potential for faster startup of the vaccine manufacturing process in the event of a pandemic, because it is not dependent on an egg supply or on availability of the influenza virus,” she said in an FDA press release.

Click here to read the full CIDRAP report.